In the RA group, the GSVA results of enriched DEGs also indicated that immunity and inflammation pathways, such as chemokine signaling, NK cell–mediated immunity, B-cell receptor signaling, primary immunodeficiency, and intestinal immune network for IgA production were evident (Figure 3D). The gene discussed is CD79A; the disease is rheumatoid arthritis.